Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

21.

Safe water, sanitation, hygiene, and a cholera vaccine.

Lancet.
Azman AS, Ivers LC, Legros D, Luquero FJ, Mintz ED.
| Jan 2, 2016
22.

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.

Lancet.
Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, Amso NN, Apostolidou S, Benjamin E, Cruickshank D, Crump DN, Davies SK, Dawnay A, Dobbs S, Fletcher G, Ford J, Godfrey K, Gunu R, Habib M, Hallett R, Herod J, Jenkins H, Karpinskyj C, Leeson S, Lewis SJ, Liston WR, Lopes A, Mould T, Murdoch J, Oram D, Rabideau DJ, Reynolds K, Scott I, Seif MW, Sharma A, Singh N, Taylor J, Warburton F, Widschwendter M, Williamson K, Woolas R, Fallowfield L, McGuire AJ, Campbell S, Parmar M, Skates SJ.
| Mar 5, 2016
23.

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.

Lancet.
Yao JC, Fazio N, Singh S, Buzzoni R, Carnaghi C, Wolin E, Tomasek J, Raderer M, Lahner H, Voi M, Pacaud LB, Rouyrre N, Sachs C, Valle JW, Delle Fave G, Van Cutsem E, Tesselaar M, Shimada Y, Oh DY, Strosberg J, Kulke MH, Pavel ME, Raderer M.
| Mar 5, 2016
24.

ReEBOV Antigen Rapid Test kit for Ebola - Authors' reply.

Lancet.
Broadhurst MJ, Semper A, Bailey D, Pollock NR.
| Dec 5, 2015
25.

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.

Lancet.
Ware RE, Davis BR, Schultz WH, Brown RC, Aygun B, Sarnaik S, Odame I, Fuh B, George A, Owen W, Luchtman-Jones L, Rogers ZR, Hilliard L, Gauger C, Piccone C, Lee MT, Kwiatkowski JL, Jackson S, Miller ST, Roberts C, Heeney MM, Kalfa TA, Nelson S, Imran H, Nottage K, Alvarez O, Rhodes M, Thompson AA, Rothman JA, Helton KJ, Roberts D, Coleman J, Bonner MJ, Kutlar A, Patel N, Wood J, Piller L, Wei P, Luden J, Mortier NA, Stuber SE, Luban NL, Cohen AR, Pressel S, Adams RJ.
| Feb 13, 2016
27.

Mortality risk with dual antiplatelet therapy?

Lancet.
Yeh RW, Elmariah S, Doros G, Kereiakes DJ, Mauri L.
| Oct 17, 2015
28.

Stopping the body count: a comprehensive approach to move towards zero tuberculosis deaths.

Lancet.
Keshavjee S, Dowdy D, Swaminathan S.
| Dec 5, 2015
29.

Data for action: collection and use of local data to end tuberculosis.

Lancet.
Theron G, Jenkins HE, Cobelens F, Abubakar I, Khan AJ, Cohen T, Dowdy DW.
| Dec 5, 2015
30.

Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment.

Lancet.
Yuen CM, Amanullah F, Dharmadhikari A, Nardell EA, Seddon JA, Vasilyeva I, Zhao Y, Keshavjee S, Becerra MC.
| Dec 5, 2015
31.

Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial.

Lancet.
Davidson AJ, Disma N, de Graaff JC, Withington DE, Dorris L, Bell G, Stargatt R, Bellinger DC, Schuster T, Arnup SJ, Hardy P, Hunt RW, Takagi MJ, Giribaldi G, Hartmann PL, Salvo I, Morton NS, von Ungern Sternberg BS, Locatelli BG, Wilton N, Lynn A, Thomas JJ, Polaner D, Bagshaw O, Szmuk P, Absalom AR, Frawley G, Berde C, Ormond GD, Marmor J, McCann ME, Davidson AJ.
| Jan 16, 2016
32.

Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials.

Lancet.
Lockley SW, Dressman MA, Licamele L, Xiao C, Fisher DM, Flynn-Evans EE, Hull JT, Torres R, Lavedan C, Polymeropoulos MH.
| Oct 31, 2015
33.

Diagnosis and treatment of acute extremity compartment syndrome.

Lancet.
von Keudell AG, Weaver MJ, Appleton PT, Appelton PT, Bae DS, Dyer GS, Heng M, Jupiter JB, Vrahas MS.
| Sep 26, 2015
34.

Reframing NCDs and injuries for the poorest billion: a Lancet Commission.

Lancet.
Bukhman G, Mocumbi AO, Horton R.
| Sep 26, 2015
36.

Antiretroviral chemoprophylaxis: PROUD and pragmatism.

Lancet.
Mayer KH, Beyrer C.
| Jan 2, 2016
37.

Hospital detention practices: statement of a global taskforce.

Lancet.
Mostert S, Lam CG, Njuguna F, Patenaude AF, Kulkarni K, Salaverria C, Arora RS.
| Aug 15, 2015
38.

Epidemiology of untreated non-obstetric surgical disease in Burera District, Rwanda: a cross-sectional survey.

Lancet.
Linden AF, Maine R, Hedt-Gauthier BL, Kamanzi E, Mody G, Ntakiyiruta G, Kansayisa G, Ntaganda E, Niyonkuru F, Mubiligi J, Mpunga T, Meara JG, Riviello R.
| Apr 27, 2015
39.

Validation of a community-based survey assessing non-obstetric surgical conditions in Burera District, Rwanda.

Lancet.
Linden AF, Maine R, Hedt-Gauthier BL, Kamanzi E, Mody G, Ntakiyiruta G, Kansayisa G, Ntaganda E, Niyonkuru F, Mubiligi J, Mpunga T, Meara JG, Riviello R.
| Apr 27, 2015
40.

Head and neck cancer in South Asia: macroeconomic consequences and the role of surgery.

Lancet.
Alkire BC, Bergmark RW, Chambers K, Cheney ML, Meara JG.
| Apr 27, 2015